Compliance Rate

Compliance Rate 50.0%
Compliant submissions 2
Incompliant submissions 2
Total trials 4

My Organizations' Clinical Trials

Showing 1175 of 1308 entries
View as:

Community Mobilization for Improved Clean Cookstove Uptake, Household Air Pollution Reduction, and Hypertension Prevention

Phase: N/A Priority: Normal
NCT ID: NCT05048147 Org: User:
Start: 04/11/23 End: 06/30/26 Due: 06/30/27

Daratumumab in STK11 Mutated NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT05807048 Org: User:
Start: 06/01/23 End: 12/31/26 Due: 12/31/27

Heart Rate Variability (HRV)-Guided Transcranial Direct Current Stimulation (tDCS)

Phase: N/A Priority: Normal
NCT ID: NCT06455527 Org: User:
Start: 01/02/25 End: 11/01/27 Due: 11/01/28

Intermittent ST Depression and Prognosis After Myocardial Infarction

Phase: N/A Priority: Normal
NCT ID: NCT00005217 Org: User:
Start: 04/30/88 End: 03/31/91 Due: 03/31/92

Neurophysiological and Functional Mechanisms of Motor Control and Learning

Phase: N/A Priority: Normal
NCT ID: NCT03190590 Org: User:
Start: 03/20/18 End: 07/18/18 Due: 07/18/19

The Physiological Effects of Pacing on Catheter Ablation Procedures to Treat Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT02766712 Org: User:
Start: 04/30/16 End: 05/02/17 Due: 05/02/18

Sphenopalatine Ganglion Block to Prevent Shoulder Pain After Laparoscopic Bariatric Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02809755 Org: User:
Start: 08/08/16 End: 04/03/17 Due: 04/03/18

Brain Sleep Deprivation MRI Effects (BEDTIME)

Phase: N/A Priority: Normal
NCT ID: NCT02741505 Org: User:
Start: 06/30/19 End: 12/01/19 Due: 12/01/20

LLLT Combined With CDT in Breast Cancer-Related Lymphedema

Phase: N/A Priority: Normal
NCT ID: NCT01351376 Org: User:
Start: 05/31/11 End: 07/31/17 Due: 07/31/18

Caregiver-Child Interaction and Health Behaviors

Phase: N/A Priority: Normal
NCT ID: NCT03162822 Org: User:
Start: 05/01/17 End: 06/30/20 Due: 06/30/21

Implementing an Effective Diabetes Intervention Among Low-Income Immigrants

Phase: N/A Priority: Normal
NCT ID: NCT06319703 Org: User:
Start: 12/29/24 End: 06/30/28 Due: 06/30/29

Acoustic Stimulation for Seizure Suppression

Phase: N/A Priority: Normal
NCT ID: NCT03198494 Org: User:
Start: 08/17/17 End: 11/21/28 Due: 11/21/29

Alcohol Versus Chlorhexidine With and Without Water

Phase: N/A Priority: Normal
NCT ID: NCT02640469 Org: User:
Start: 12/31/16 End: 01/31/18 Due: 01/31/19

A Randomized, Single Center Pilot Study Comparing Hyaluronic Acid to Vaginal Estrogen for Treatment of Genitourinary Syndrome of Menopause

Phase: N/A Priority: Normal
NCT ID: NCT04544475 Org: User:
Start: 09/01/21 End: 10/03/22 Due: 10/03/23

Association Between Inpatient Steps Per Day and Patient Functional Status/Disposition

Phase: N/A Priority: Normal
NCT ID: NCT03595605 Org: User:
Start: 05/16/18 End: 03/30/19 Due: 03/30/20

A Pragmatic Trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) Model for Engaging Patients in Opioid Use Disorder Treatment

Phase: N/A Priority: Normal
NCT ID: NCT03611335 Org: User:
Start: 12/07/18 End: 03/20/23 Due: 03/20/24

Topotecan With Erlotinib for Topotecan Pretreated Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01003938 Org: User:
Start: 08/31/09 End: 12/31/12 Due: 12/31/13

Identify Predictors That Distinguish Between Tofacitinib Responders and Non-responders Based on Genotype and Cellular and Molecular Profiles From Pinch Biopsies, Blood and Stool Samples

Phase: N/A Priority: Normal
NCT ID: NCT03663400 Org: User:
Start: 12/04/18 End: 03/24/22 Due: 03/24/23

A Phase II a Study of Lenvatinib, a Multi-targeted Tyrosine Kinase Inhibitor, Combined With Pembrolizumab (PD-1 Inhibitor) for the Treatment of Metastatic Gastroesophageal Cancer Patients Who Have Progressed on First or Subsequent Line Therapies

Phase: N/A Priority: Normal
NCT ID: NCT03321630 Org: User:
Start: 10/24/17 End: 01/16/24 Due: 01/16/25

Pupillary Dilation During Post-Auricular Vagal Nerve Stimulation

Phase: N/A Priority: Normal
NCT ID: NCT05870527 Org: User:
Start: 07/10/23 End: 06/30/26 Due: 06/30/27

Study of Concurrent Paclitaxel and Radiation: Correlation of Tumor Profiles With Pathologic Response

Phase: N/A Priority: Normal
NCT ID: NCT02280252 Org: User:
Start: 03/31/05 End: 12/20/18 Due: 12/20/19

Early Independent Adaptive Arm and Hand Rehab

Phase: N/A Priority: Normal
NCT ID: NCT02749500 Org: User:
Start: 06/01/17 End: 01/19/19 Due: 01/19/20

Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of Progression

Phase: N/A Priority: Normal
NCT ID: NCT00659399 Org: User:
Start: 01/31/08 End: 11/30/10 Due: 11/30/11

Study of Nivolumab With or Without Pazopanib in Metastatic or Unresectable Soft Tissue Sarcomas

Phase: N/A Priority: Normal
NCT ID: NCT03149120 Org: User:
Start: 08/31/17 End: 06/30/22 Due: 06/30/23

Ataluren for Nonsense Mutation in CDKL5 and Dravet Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02758626 Org: User:
Start: 11/30/16 End: 02/27/21 Due: 02/27/22